ZA976368B - High-affinity interleukin-4 muteins. - Google Patents
High-affinity interleukin-4 muteins.Info
- Publication number
- ZA976368B ZA976368B ZA9706368A ZA976368A ZA976368B ZA 976368 B ZA976368 B ZA 976368B ZA 9706368 A ZA9706368 A ZA 9706368A ZA 976368 A ZA976368 A ZA 976368A ZA 976368 B ZA976368 B ZA 976368B
- Authority
- ZA
- South Africa
- Prior art keywords
- muteins
- affinity interleukin
- interleukin
- affinity
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6869—Interleukin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68780396A | 1996-07-19 | 1996-07-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA976368B true ZA976368B (en) | 1998-02-19 |
Family
ID=24761912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9706368A ZA976368B (en) | 1996-07-19 | 1997-07-18 | High-affinity interleukin-4 muteins. |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0939817B1 (zh) |
JP (1) | JP2000515016A (zh) |
KR (1) | KR100468553B1 (zh) |
CN (1) | CN1201006C (zh) |
AR (2) | AR007917A1 (zh) |
AT (1) | ATE310821T1 (zh) |
AU (1) | AU718794B2 (zh) |
BR (1) | BR9710733B1 (zh) |
CA (1) | CA2259940C (zh) |
DE (1) | DE69734723T2 (zh) |
DK (1) | DK0939817T3 (zh) |
ES (1) | ES2252786T3 (zh) |
HK (1) | HK1022717A1 (zh) |
HU (1) | HU224973B1 (zh) |
ID (1) | ID17491A (zh) |
IL (2) | IL127934A0 (zh) |
MY (1) | MY124565A (zh) |
NZ (2) | NZ505238A (zh) |
PL (1) | PL188738B1 (zh) |
RU (1) | RU2202364C2 (zh) |
TR (1) | TR199900100T2 (zh) |
TW (1) | TW496871B (zh) |
WO (1) | WO1998003654A2 (zh) |
ZA (1) | ZA976368B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0911401A1 (en) * | 1997-10-21 | 1999-04-28 | Bayer Ag | Muteins of interleukin 4 showing low-affinity and short-term interaction with the common gamma chain |
EP1022337B1 (en) * | 1999-01-20 | 2006-07-26 | Bayer HealthCare AG | Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
DE69929638T2 (de) | 1999-01-20 | 2006-09-21 | Bayer Healthcare Ag | Plasmide, deren Konstruktion und Anwendung zur Herstellung von Interleukin-4 und dessen Muteine |
CN1306030C (zh) * | 2001-09-28 | 2007-03-21 | 中山大学 | 一种人白细胞介素-10基因序列及含该基因序列的大肠杆菌 |
WO2004064860A1 (en) * | 2003-01-17 | 2004-08-05 | Children's Hospital Medical Center | Use of tff2, or agents inducing tff2, in the therapy of allergies |
US7404957B2 (en) | 2003-08-29 | 2008-07-29 | Aerovance, Inc. | Modified IL-4 mutein receptor antagonists |
US7785580B2 (en) | 2003-08-29 | 2010-08-31 | Aerovance, Inc. | Modified IL-4 mutein receptor antagonists |
JP2009525267A (ja) * | 2006-01-11 | 2009-07-09 | アエロヴァンス インコーポレイティッド | ヒトおよび非ヒト霊長類において喘息を処置するための方法および組成物 |
WO2017001568A1 (en) | 2015-07-01 | 2017-01-05 | Universitat De Lleida | Treatment and prevention of amyotrophic lateral sclerosis |
CN113227369A (zh) * | 2018-12-19 | 2021-08-06 | 生物制药翻译学院德绍研究有限公司 | 具有改善的酶学特性的胰蛋白酶变体 |
CN113527485A (zh) * | 2020-04-17 | 2021-10-22 | 上海麦济生物技术有限公司 | 抗人白细胞介素-4受体α抗体及其制备方法和应用 |
CN112442504B (zh) * | 2020-12-10 | 2023-01-24 | 电子科技大学 | 一种重组草鱼白介素-12活性蛋白的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988004667A1 (en) * | 1986-12-19 | 1988-06-30 | Immunex Corporation | Human interleukin-4 muteins |
DE4137333A1 (de) * | 1991-11-13 | 1993-05-19 | W Prof Dr Sebald | Therapeutische mittel, die antagonisten oder partielle agonisten des humanen interleukin 4 sind oder diese enthalten, hil-4-mutantenproteine sowie vefahren zu deren herstellung |
AU4289193A (en) * | 1992-04-17 | 1993-11-18 | University Hospital, The | Mutant cytokines having increased receptor affinity |
CA2256459A1 (en) * | 1996-06-14 | 1997-12-18 | Bayer Corporation | T-cell selective interleukin-4 agonists |
-
1997
- 1997-07-04 MY MYPI97003051A patent/MY124565A/en unknown
- 1997-07-09 TR TR1999/00100T patent/TR199900100T2/xx unknown
- 1997-07-09 EP EP97933333A patent/EP0939817B1/en not_active Expired - Lifetime
- 1997-07-09 DK DK97933333T patent/DK0939817T3/da active
- 1997-07-09 PL PL97331253A patent/PL188738B1/pl not_active IP Right Cessation
- 1997-07-09 KR KR10-1999-7000371A patent/KR100468553B1/ko not_active IP Right Cessation
- 1997-07-09 IL IL12793497A patent/IL127934A0/xx not_active IP Right Cessation
- 1997-07-09 RU RU99103688/14A patent/RU2202364C2/ru not_active IP Right Cessation
- 1997-07-09 CN CNB971979596A patent/CN1201006C/zh not_active Expired - Fee Related
- 1997-07-09 DE DE69734723T patent/DE69734723T2/de not_active Expired - Lifetime
- 1997-07-09 CA CA002259940A patent/CA2259940C/en not_active Expired - Fee Related
- 1997-07-09 HU HU0000248A patent/HU224973B1/hu not_active IP Right Cessation
- 1997-07-09 ES ES97933333T patent/ES2252786T3/es not_active Expired - Lifetime
- 1997-07-09 AU AU36545/97A patent/AU718794B2/en not_active Ceased
- 1997-07-09 BR BRPI9710733-6A patent/BR9710733B1/pt not_active IP Right Cessation
- 1997-07-09 JP JP10506976A patent/JP2000515016A/ja not_active Ceased
- 1997-07-09 AT AT97933333T patent/ATE310821T1/de active
- 1997-07-09 NZ NZ505238A patent/NZ505238A/en not_active IP Right Cessation
- 1997-07-09 NZ NZ333748A patent/NZ333748A/xx not_active IP Right Cessation
- 1997-07-09 WO PCT/US1997/011909 patent/WO1998003654A2/en active IP Right Grant
- 1997-07-15 TW TW086109934A patent/TW496871B/zh not_active IP Right Cessation
- 1997-07-18 AR ARP970103229A patent/AR007917A1/es active IP Right Grant
- 1997-07-18 ZA ZA9706368A patent/ZA976368B/xx unknown
- 1997-07-21 ID IDP972537A patent/ID17491A/id unknown
-
2000
- 2000-03-10 HK HK00101505A patent/HK1022717A1/xx not_active IP Right Cessation
-
2007
- 2007-04-12 IL IL182509A patent/IL182509A/en not_active IP Right Cessation
- 2007-04-24 AR ARP070101757A patent/AR060630A2/es active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2319523B (en) | Hydroxyphenyltriazines | |
GB2317174B (en) | Hydroxyphenyltriazines | |
ZA972685B (en) | Medicaments. | |
DE69723848D1 (en) | 3-descladinose-2,3-anhydroerythromycin-derivate | |
ZA976368B (en) | High-affinity interleukin-4 muteins. | |
GB9618974D0 (en) | Medicaments | |
GB9611947D0 (en) | Medicaments | |
GB9605293D0 (en) | Medicaments | |
IL125919A0 (en) | Cytokine designated lerk-8 | |
GB9611167D0 (en) | Medicaments | |
GB9619677D0 (en) | Table | |
GB9613096D0 (en) | Medicaments | |
ZA97533B (en) | Table tennis table. | |
ZA971302B (en) | Novel cytokine. | |
CA79135S (en) | Table | |
CA79134S (en) | Table | |
GB9611319D0 (en) | Novel cytokine | |
PL104431U1 (en) | Table | |
AU128694S (en) | Table | |
PL104271U1 (en) | Small at-the-bed table | |
GB9605859D0 (en) | Medicaments | |
GB9605329D0 (en) | Medicaments | |
GB9618975D0 (en) | Medicaments | |
GB9623160D0 (en) | Medicaments | |
GB9605328D0 (en) | Medicaments |